KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Current Assets (2017 - 2025)

Historic Current Assets for Cardlytics (CDLX) over the last 9 years, with Q3 2025 value amounting to $140.7 million.

  • Cardlytics' Current Assets fell 2324.77% to $140.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.7 million, marking a year-over-year decrease of 2324.77%. This contributed to the annual value of $178.0 million for FY2024, which is 2051.78% down from last year.
  • According to the latest figures from Q3 2025, Cardlytics' Current Assets is $140.7 million, which was down 2324.77% from $150.4 million recorded in Q2 2025.
  • Cardlytics' Current Assets' 5-year high stood at $702.6 million during Q1 2021, with a 5-year trough of $140.7 million in Q3 2025.
  • In the last 5 years, Cardlytics' Current Assets had a median value of $223.9 million in 2023 and averaged $258.3 million.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 31317.62% in 2021, then tumbled by 5453.28% in 2022.
  • Quarter analysis of 5 years shows Cardlytics' Current Assets stood at $358.7 million in 2021, then crashed by 30.3% to $250.0 million in 2022, then dropped by 10.44% to $223.9 million in 2023, then dropped by 20.52% to $178.0 million in 2024, then dropped by 20.94% to $140.7 million in 2025.
  • Its Current Assets was $140.7 million in Q3 2025, compared to $150.4 million in Q2 2025 and $156.8 million in Q1 2025.